Fatemeh Talebian, Ph.D.

Affiliations: 
2012 Integrated Biomedical Science Graduate Program (IBGP) Ohio State University, Columbus, Columbus, OH 
Area:
Immunology
Google:
"Fatemeh Talebian"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Xue-Feng Bai grad student 2012 Ohio State
 (CD200-CD200R Interaction in Tumor Immunity.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Liu JQ, Hu A, Zhu J, et al. (2020) CD200-CD200R Pathway in the Regulation of Tumor Immune Microenvironment and Immunotherapy. Advances in Experimental Medicine and Biology. 1223: 155-165
Liu JQ, Talebian F, Wu L, et al. (2016) A Critical Role for CD200R Signaling in Limiting the Growth and Metastasis of CD200+ Melanoma. Journal of Immunology (Baltimore, Md. : 1950)
Wang L, Liu JQ, Talebian F, et al. (2015) IL-10 enhances CTL-mediated tumor rejection by inhibiting highly suppressive CD4(+) T cells and promoting CTL persistence in a murine model of plasmacytoma. Oncoimmunology. 4: e1014232
Liu Z, Liu JQ, Talebian F, et al. (2013) IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells. European Journal of Immunology. 43: 468-79
Talebian F, Bai XF. (2012) The role of tumor expression of CD200 in tumor formation, metastasis and susceptibility to T lymphocyte adoptive transfer therapy. Oncoimmunology. 1: 971-973
Liu JQ, Liu Z, Zhang X, et al. (2012) Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 188: 3099-106
Talebian F, Liu JQ, Liu Z, et al. (2012) Melanoma cell expression of CD200 inhibits tumor formation and lung metastasis via inhibition of myeloid cell functions. Plos One. 7: e31442
Wang LX, Talebian F, Liu JQ, et al. (2012) IL-10 contributes to the suppressive function of tumour-associated myeloid cells and enhances myeloid cell accumulation in tumours. Scandinavian Journal of Immunology. 75: 273-81
Wang L, Liu JQ, Talebian F, et al. (2010) Tumor expression of CD200 inhibits IL-10 production by tumor-associated myeloid cells and prevents tumor immune evasion of CTL therapy. European Journal of Immunology. 40: 2569-79
See more...